Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Maʻemaʻe >99.5% EE >99.5%

ʻO ka wehewehe pōkole:

Inoa: Boc-3-Hydroxy-1-Adamantyl-D-Glycine

CAS: 361442-00-4

Maʻemaʻe: >99.5% (GC) EE: >99.5%

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

Waena o API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

ʻO Ruifu Chemical Supply pili i waena
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7

Na Waiwai Kemika:

Inoa Kimia	Boc-3-Hydroxy-1-Adamantyl-D-Glycine
Nā huaʻōlelo like	(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl)acetic Acid
Helu CAS	361442-00-4
Helu CAT	RF-PI1989
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C17H27NO5
Kaumaha Molecular	325.40
Lae paila	497.3±20.0 ℃
ʻO ka mānoanoa	1.296
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a i ʻole ke keʻokeʻo Crystalline pauda
Wai (KF)	<0.50%
Nalo ma ka maloo	<1.00%
Koena ma ka Ignition	<0.50%
Hoʻokahi haumia	<0.50%
Huina paumaele	<0.50%
EE	>99.5%
Maemae	>99.5%
Infrared Spectrum	Kūlike i ka hoʻolālā
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Nā Kūwaena Lapaʻau

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

ʻO Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) he mea waena o API (CAS: 361442-04-8).API (CAS: 361442-04-8)He mea hoʻopaneʻe ikaika a koho hoʻi i ka dipeptidyl peptidase-4, i kūkulu ʻia no ka mālama ʻana i ka maʻi diabetes type 2.Hoʻopili koke ʻia ma hope o ka hoʻokele waha a loaʻa iā ia kahi ʻōlelo pharmacokinetic kūpono me ka hoʻohana ʻana i hoʻokahi manawa i kēlā me kēia lā.He dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic no ka mālama ʻana i ka maʻi diabetes type 2.ʻO ka DPP-4 inhibitors kahi papa o nā pūhui e hana ana ma ka hoʻopili ʻana i ka hana o nā hormones maoli i loko o ke kino i kapa ʻia ʻo incretins.ʻO iaHoʻohana pū ʻia me ka meaʻai a me ka hoʻomaʻamaʻa e hoʻomaikaʻi i ke kō koko koko i nā pākeke me ka maʻi diabetes type 2.ʻAʻole ia no ka mālama ʻana i ka maʻi diabetes type 1.ʻO iaHoʻohana ʻia i kekahi manawa me nā lāʻau maʻi diabetes ʻē aʻe.Ua hōʻea ʻia e ka hui pū ʻana o AstraZeneca a me Bristol-Myers Squibb Company a nona ka DPP-IV inhibitor.